Select Medical Holdings (NYSE: SEM) reported Q4 EPS of $0.36, $0.02 better than the analyst estimate of $0.34. Revenue for the quarter came in at $1.66 billion versus the consensus estimate of $1.64 billion.

Select Medical is issuing its business outlook for 2024. Select Medical expects revenue to be in the range of $6.9 billion to $7.1 billion, Adjusted EBITDA to be in the range of $830 million to $880 million, and fully diluted earnings per share to be in the range of $1.88 to $2.18. A reconciliation of full year 2024 Adjusted EBITDA expectations to net income is presented in table XI of this release.

For earnings history and earnings-related data on Select Medical Holdings (SEM) click here.